Neuroprotective effects of an <em>in vitro</em> BBB permeable phenoxythiophene sulfonamide small molecule in glutamate‑induced oxidative injury

Pokharel,Smritee; Gliyazova,Nailya S.; Dandepally,Srinivasa R.; Williams,Alfred L.; Ibeanu,Gordon C.

doi:10.3892/etm.2021.11002

Neuroprotective effects of an in vitro BBB permeable phenoxythiophene sulfonamide small molecule in glutamate‑induced oxidative injury

Authors:
- Smritee Pokharel
- Nailya S. Gliyazova
- Srinivasa R. Dandepally
- Alfred L. Williams
- Gordon C. Ibeanu
View Affiliations

Affiliations: Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, NC 27707, USA
Published online on: November 25, 2021 https://doi.org/10.3892/etm.2021.11002
Article Number: 79

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Reactive oxygen species (ROS) play a central role in oxidative stress‑associated neuronal cell death during ischemia. Further investigation into the inhibition of excessive ROS generation post‑stroke is urgently required for the treatment of ischemic stroke. In the present study, the neuroprotective properties of the blood‑brain barrier (BBB) penetrant B355227 were investigated. B355227 is a chemical analogue of B355252, and the role of the phenoxythiophene sulfonamide compound B355227 was further investigated in a glutamate‑induced oxidative injury model. An in vitro model of the BBB was established in the immortalized mouse brain capillary endothelial cell line, bEnd.3. Formation of barrier in Transwell inserts was confirmed using EVOM resistance meter and Caffeine, Imatinib and Axitinib were used to validate the efficacy of the model. The validated BBB assay in combination with high performance liquid chromatography were used to analyse and verify the permeability of B355227 through the barrier. The integrity of the cell junctions after the BBB assays were confirmed using immunofluorescence to visualize the expression of the barrier junction protein zonula occludens‑1. Cell survival was measured with Resazurin, a redox indicator dye, in HT22, a hippocampal neuronal cell treated with 5 mM glutamate or co‑treated with the B355227 recovered from the BBB permeability experiment. Changes in glutathione levels were detected using a glutathione detection kit, while analyses of ROS, calcium (Ca²⁺), and mitochondrial membrane potential (MMP) were accomplished with the fluorescent dyes 2',7'‑dichlorofluorescein diacetate, Fura‑2 AM and MitoTracker Red dyes, respectively. Immunoblotting was also performed to detect the expression and activation of Erk1/2, p‑38, JNK, Bax and Bcl‑2. The results of the present study demonstrated that B355227 crossed the BBB in vitro and protected HT22 from oxidative injury induced by glutamate exposure. Treatment of cells with B355227 blocked the glutamate‑dependent depletion of intracellular glutathione and significantly reduced ROS production. Increased Ca²⁺ influx and subsequent collapse of the MMP was attenuated by B355227. Furthermore, the results of the present study demonstrated that B355227 protected against oxidative stress via the MAPK pathway, by increasing the activation of Erk1/2, JNK and P38, and restoring anti‑apoptotic Bcl‑2. Collectively, the results of the present study indicate that B355227 has potent antioxidant and neuroprotective attributes in glutamate‑induced neuronal cell death. Further investigation into the role of B355227 in the modulation of glutamate‑dependent oxidative stress is required.

View Figures

View References

1	Barthels D and Das H: Current advances in ischemic stroke research and therapies. Biochim Biophys Acta Mol Basis Dis. 1866(165260)2020.PubMed/NCBI View Article : Google Scholar
2	Lee CH and Lee SH: General facts of stroke. In: Stroke Revisited: Pathophysiology of Stroke: From Bench to Bedside. Lee SH (ed). Springer, Singapore, pp3-10, 2020.
3	Deb P, Sharma S and Hassan KM: Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology. 17:197–218. 2010.PubMed/NCBI View Article : Google Scholar
4	Mergenthaler P, Dirnagl U and Meisel A: Pathophysiology of stroke: Lessons from animal models. Metab Brain Dis. 19:151–167. 2004.PubMed/NCBI View Article : Google Scholar
5	Jansson LC and Åkerman KE: The role of glutamate and its receptors in the proliferation, migration, differentiation and survival of neural progenitor cells. J Neural Transm (Vienna). 121:819–836. 2014.PubMed/NCBI View Article : Google Scholar
6	McEntee WJ and Crook TH: Glutamate: Its role in learning, memory, and the aging brain. Psychopharmacology (Berl). 111:391–401. 1993.PubMed/NCBI View Article : Google Scholar
7	Foran E and Trotti D: Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal. 11:1587–1602. 2009.PubMed/NCBI View Article : Google Scholar
8	Bridges RJ, Natale NR and Patel SA: System xc^- cystine/glutamate antiporter: An update on molecular pharmacology and roles within the CNS. Br J Pharmacol. 165:20–34. 2012.PubMed/NCBI View Article : Google Scholar
9	Shih AY, Erb H, Sun X, Toda S, Kalivas PW and Murphy TH: Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci. 26:10514–10523. 2006.PubMed/NCBI View Article : Google Scholar
10	Angelova PR, Vinogradova D, Neganova ME, Serkova TP, Sokolov VV, Bachurin SO, Shevtsova EF and Abramov AY: Pharmacological sequestration of mitochondrial calcium uptake protects neurons against glutamate excitotoxicity. Mol Neurobiol. 56:2244–2255. 2019.PubMed/NCBI View Article : Google Scholar
11	Meredith GE, Totterdell S, Beales M and Meshul CK: Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease. Exp Neurol. 219:334–340. 2009.PubMed/NCBI View Article : Google Scholar
12	Nozaki K, Nishimura M and Hashimoto N: Mitogen-activated protein kinases and cerebral ischemia. Mol Neurobiol. 23:1–19. 2001.PubMed/NCBI View Article : Google Scholar
13	Satoh T, Nakatsuka D, Watanabe Y, Nagata I, Kikuchi H and Namura S: Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci Lett. 288:163–166. 2000.PubMed/NCBI View Article : Google Scholar
14	Shioda N, Han F and Fukunaga K: Role of Akt and ERK signaling in the neurogenesis following brain ischemia. Int Rev Neurobiol. 85:375–387. 2009.PubMed/NCBI View Article : Google Scholar
15	Chen RW, Qin ZH, Ren M, Kanai H, Chalecka-Franaszek E, Leeds P and Chuang DM: Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: Roles in glutamate excitotoxicity and lithium neuroprotection. J Neurochem. 84:566–575. 2003.PubMed/NCBI View Article : Google Scholar
16	Williams AL, Dandepally SR, Gilyazova N, Witherspoon SM and Ibeanu G: Microwave-assisted synthesis of 4-chloro-N-(naphthalen-1-ylmethyl)-5-(3-(piperazin-1-yl)phenoxy)thiophene-2-sulfonamide(B-355252): A new potentiator of Nerve Growth Factor (NGF)-induced neurite outgrowth. Tetrahedron. 66:9577–9581. 2010.PubMed/NCBI View Article : Google Scholar
17	Chimeh U, Zimmerman MA, Gilyazova N and Li PA: B355252, a novel small molecule, confers neuroprotection against cobalt chloride toxicity in mouse hippocampal cells through altering mitochondrial dynamics and limiting autophagy induction. Int J Med Sci. 15:1384–1396. 2018.PubMed/NCBI View Article : Google Scholar
18	Gliyazova NS, Huh EY and Ibeanu GC: A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell model. BMC Neurosci. 14(93)2013.PubMed/NCBI View Article : Google Scholar
19	Gliyazova NS and Ibeanu GC: The chemical molecule B355252 is neuroprotective in an in vitro model of Parkinson's disease. Cell Mol Neurobiol. 36:1109–1122. 2016.PubMed/NCBI View Article : Google Scholar
20	Pokharel S, Kamli MR, Mir BA, Malik A, Lee EJ and Choi I: Expression of transthyretin during bovine myogenic satellite cell differentiation. In Vitro Cell Dev Biol Anim. 50:756–765. 2014.PubMed/NCBI View Article : Google Scholar
21	Pokharel S, Lee CH, Gilyazova N and Ibeanu GC: Analysis of gene expression and neuronal phenotype in neuroscreen-1 (NS-1) Cells. Int J Biomed Investig. 1:1–13. 2018.PubMed/NCBI
22	Brown RC, Morris AP and O'Neil RG: Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res. 1130:17–30. 2007.PubMed/NCBI View Article : Google Scholar
23	Birben E, Sahiner UM, Sackesen C, Erzurum S and Kalayci O: Oxidative stress and antioxidant defense. World Allergy Organ J. 5:9–19. 2012.PubMed/NCBI View Article : Google Scholar
24	Baquer NZ, Taha A, Kumar P, McLean P, Cowsik SM, Kale RK, Singh R and Sharma D: A metabolic and functional overview of brain aging linked to neurological disorders. Biogerontology. 10:377–413. 2009.PubMed/NCBI View Article : Google Scholar
25	Görlach A, Bertram K, Hudecova S and Krizanova O: Calcium and ROS: A mutual interplay. Redox Biol. 6:260–271. 2015.PubMed/NCBI View Article : Google Scholar
26	Feno S, Butera G, Vecellio Reane D, Rizzuto R and Raffaello A: Crosstalk between Calcium and ROS in Pathophysiological Conditions. Oxid Med Cell Longev. 2019(9324018)2019.PubMed/NCBI View Article : Google Scholar
27	Kumari S, Mehta SL and Li PA: Glutamate induces mitochondrial dynamic imbalance and autophagy activation: Preventive effects of selenium. PLoS One. 7(e39382)2012.PubMed/NCBI View Article : Google Scholar
28	Singer CA, Figueroa-Masot XA, Batchelor RH and Dorsa DM: The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci. 19:2455–2463. 1999.PubMed/NCBI View Article : Google Scholar
29	Yamazaki Y, Arita K, Harada S and Tokuyama S: Activation of c-Jun N-terminal kinase and p38 after cerebral ischemia upregulates cerebral sodium-glucose transporter type 1. J Pharmacol Sci. 138:240–246. 2018.PubMed/NCBI View Article : Google Scholar
30	Pardridge WM: Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 32:1959–1972. 2012.PubMed/NCBI View Article : Google Scholar
31	Banks WA: Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 9 (Suppl 1)(S3)2009.PubMed/NCBI View Article : Google Scholar
32	Koto T, Takubo K, Ishida S, Shinoda H, Inoue M, Tsubota K, Okada Y and Ikeda E: Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol. 170:1389–1397. 2007.PubMed/NCBI View Article : Google Scholar
33	Yang S, Mei S, Jin H, Zhu B, Tian Y, Huo J, Cui X, Guo A and Zhao Z: Identification of two immortalized cell lines, ECV304 and bEnd3, for in vitro permeability studies of blood-brain barrier. PLoS One. 12(e0187017)2017.PubMed/NCBI View Article : Google Scholar
34	Stamatovic SM, Johnson AM, Keep RF and Andjelkovic AV: Junctional proteins of the blood-brain barrier: New insights into function and dysfunction. Tissue Barriers. 4(e1154641)2016.PubMed/NCBI View Article : Google Scholar
35	Katsuno T, Umeda K, Matsui T, Hata M, Tamura A, Itoh M, Takeuchi K, Fujimori T, Nabeshima Y, Noda T, et al: Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. Mol Biol Cell. 19:2465–2475. 2008.PubMed/NCBI View Article : Google Scholar
36	Belov Kirdajova D, Kriska J, Tureckova J and Anderova M: Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells. Front Cell Neurosci. 14(51)2020.PubMed/NCBI View Article : Google Scholar
37	Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E and Passarella S: Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 497:1–5. 2001.PubMed/NCBI View Article : Google Scholar
38	Kho AR, Choi BY, Lee SH, Hong DK, Lee SH, Jeong JH, Park KH, Song HK, Choi HC and Suh SW: Effects of protocatechuic acid (PCA) on global cerebral ischemia-induced hippocampal neuronal death. Int J Mol Sci. 19(19)2018.PubMed/NCBI View Article : Google Scholar
39	Chen GJ and Yang MS: The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: A meta-analysis of data from 273,543 participants in 31 randomized controlled trials. PLoS One. 8(e57854)2013.PubMed/NCBI View Article : Google Scholar
40	Ha JS and Park SS: Glutamate-induced oxidative stress, but not cell death, is largely dependent upon extracellular calcium in mouse neuronal HT22 cells. Neurosci Lett. 393:165–169. 2006.PubMed/NCBI View Article : Google Scholar
41	Abramov AY and Duchen MR: Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity. Biochim Biophys Acta. 1777:953–964. 2008.PubMed/NCBI View Article : Google Scholar
42	Tait SW and Green DR: Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 11:621–632. 2010.PubMed/NCBI View Article : Google Scholar
43	Park JS, Park JH and Kim KY: Neuroprotective effects of myristargenol A against glutamate-induced apoptotic HT22 cell death. RSC Advances. 9:31247–31254. 2019.
44	Tan S, Wood M and Maher P: Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J Neurochem. 71:95–105. 1998.PubMed/NCBI View Article : Google Scholar
45	Weon JB, Yun BR, Lee J, Eom MR, Ko HJ, Lee HY, Park DS, Chung HC, Chung JY and Ma CJ: Neuroprotective effect of steamed and fermented Codonopsis lanceolata. Biomol Ther (Seoul). 22:246–253. 2014.PubMed/NCBI View Article : Google Scholar
46	Fukui M, Song JH, Choi J, Choi HJ and Zhu BT: Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells. Eur J Pharmacol. 617:1–11. 2009.PubMed/NCBI View Article : Google Scholar
47	Levinthal DJ and Defranco DB: Reversible oxidation of ERK-directed protein phosphatases drives oxidative toxicity in neurons. J Biol Chem. 280:5875–5883. 2005.PubMed/NCBI View Article : Google Scholar
48	Kim SH, Kim KY, Park SG, Yu SN, Kim YW, Nam HW, An HH, Kim YW and Ahn SC: Mitochondrial ROS activates ERK/autophagy pathway as a protected mechanism against deoxypodophyllotoxin-induced apoptosis. Oncotarget. 8:111581–111596. 2017.PubMed/NCBI View Article : Google Scholar
49	Sato K, Yamanaka Y, Asakura Y and Nedachi T: Glutamate levels control HT22 murine hippocampal cell death by regulating biphasic patterns of Erk1/2 activation: Role of metabolic glutamate receptor 5. Biosci Biotechnol Biochem. 80:712–718. 2016.PubMed/NCBI View Article : Google Scholar
50	Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G, Reynolds I, Klann E, Angiolieri MR, Johnson JW, et al: Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem. 275:12200–12206. 2000.PubMed/NCBI View Article : Google Scholar
51	Yang DD, Kuan CY, Whitmarsh AJ, Rincón M, Zheng TS, Davis RJ, Rakic P and Flavell RA: Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 389:865–870. 1997.PubMed/NCBI View Article : Google Scholar
52	Lee HJ, Spandidos DA, Tsatsakis A, Margina D, Izotov BN and Yang SH: Neuroprotective effects of Scrophularia buergeriana extract against glutamate-induced toxicity in SH-SY5Y cells. Int J Mol Med. 43:2144–2152. 2019.PubMed/NCBI View Article : Google Scholar
53	Zhang G, Zhang T, Wu L, Zhou X, Gu J, Li C, Liu W, Long C, Yang X, Shan L, et al: Neuroprotective effect and mechanism of action of tetramethylpyrazine nitrone for ischemic stroke therapy. Neuromolecular Med. 20:97–111. 2018.PubMed/NCBI View Article : Google Scholar